title: Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors.
abstract: Nicotinic acetylcholine receptors are ligand-gated ion conducting transmembrane channels from the Cys-loop receptor super-family. The α4β2 subtype is the predominant heteromeric subtype of nicotinic receptors found in the brain. Allosteric modulators for α4β2 receptors interact at a site other than the orthosteric site where acetylcholine binds. Many compounds which act as allosteric modulators of the α4β2 receptors have been identified, with both positive and negative effects. Such allosteric modulators either increase or decrease the response induced by agonist on the α4β2 receptors. Here we discuss the concept of allosterism as it pertains to the α4β2 receptors and summarize the important features of allosteric modulators for this nicotinic receptor subtype.
authors: Laboratory of Neurobiology, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC 27709, USA. pandyaaa@niehs.nih.gov
authors: Anshul
authors: A
authors: Pandya
authors: Jerrel L
authors: JL
authors: Yakel
references: Adv Protein Chem Struct Biol. 2010;80:153-203
references: 21109220
references: J Nutr. 2000 May;130(5S Suppl):1471S-83S
references: 10801962
references: Rev Physiol Biochem Pharmacol. 2003;147:1-46
references: 12783266
references: Bioorg Med Chem Lett. 2008 Oct 1;18(19):5209-12
references: 18789861
references: Br J Pharmacol. 2000 Apr;129(8):1794-800
references: 10780988
references: Biochem Pharmacol. 2007 Oct 15;74(8):1155-63
references: 17707779
references: J Nat Prod. 2002 Nov;65(11):1633-7
references: 12444689
references: Behav Brain Res. 2000 Aug;113(1-2):199-206
references: 10942046
references: J Neurochem. 2000 Dec;75(6):2492-500
references: 11080202
references: Prog Neurobiol. 2004 Dec;74(6):363-96
references: 15649582
references: J Pharmacol Exp Ther. 2009 Feb;328(2):364-70
references: 19023041
references: J Physiol. 2010 Feb 15;588(Pt 4):597-602
references: 19917567
references: Eur J Pharmacol. 2009 Mar 1;605(1-3):114-6
references: 19168054
references: J Pharmacol Exp Ther. 1999 Dec;291(3):1127-34
references: 10565833
references: Mol Pharmacol. 2002 Jan;61(1):127-35
references: 11752213
references: Trends Neurosci. 1993 May;16(5):181-6
references: 7685943
references: Bioorg Med Chem Lett. 2008 Oct 15;18(20):5643-7
references: 18805006
references: Neuroscience. 2004;124(4):817-22
references: 15026122
references: Mol Pharmacol. 1998 May;53(5):950-62
references: 9584223
references: Neuron. 2005 May 19;46(4):595-607
references: 15944128
references: Brain Res Mol Brain Res. 2004 Apr 7;123(1-2):81-90
references: 15046869
references: J Pharmacol Exp Ther. 1994 Aug;270(2):768-78
references: 8071869
references: J Neurosci. 2001 Sep 1;21(17):6561-8
references: 11517245
references: Mol Pharmacol. 1998 Mar;53(3):555-63
references: 9495824
references: Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9949-53
references: 1409725
references: J Physiol. 1999 Oct 1;520 Pt 1:53-64
references: 10517800
references: Mol Pharmacol. 1992 Jan;41(1):31-7
references: 1732720
references: Neurosci Lett. 2005 Jan 10;373(2):144-9
references: 15567570
references: Biochim Biophys Acta. 1998 Aug 21;1376(2):173-220
references: 9748559
references: J Pharmacol Exp Ther. 2003 Jun;305(3):1024-36
references: 12649296
references: Trends Pharmacol Sci. 1997 Nov;18(11):425-9
references: 9426470
references: Trends Pharmacol Sci. 1995 May;16(5):162-8
references: 7624971
references: J Neurosci. 2005 Apr 27;25(17):4396-405
references: 15858066
references: Neuropharmacology. 2009 Jan;56(1):237-46
references: 18723036
references: Br J Pharmacol. 2008 Mar;153(5):1062-71
references: 18204487
references: J Pharmacol Exp Ther. 2010 Sep 1;334(3):917-26
references: 20516140
references: Eur J Pharmacol. 2005 Feb 21;509(2-3):97-108
references: 15733544
references: Psychopharmacology (Berl). 2004 Sep;175(2):241-6
references: 14997275
references: Bioorg Med Chem Lett. 2007 Sep 1;17(17):4855-60
references: 17604168
references: Acta Pharm Suec. 1983;20(6):415-8
references: 6675420
references: J Neurosci. 2008 Jul 2;28(27):6884-94
references: 18596163
references: Neuropharmacology. 1991 Dec;30(12B):1387-9
references: 1723508
references: Nature. 1989 Apr 13;338(6216):582-5
references: 2538761
references: Neuropharmacology. 2009 Jul;57(1):60-6
references: 19393252
references: Mol Pharmacol. 1998 Dec;54(6):1124-31
references: 9855643
references: Biol Psychiatry. 2001 Feb 1;49(3):279-88
references: 11230879
references: Mol Pharmacol. 2000 Aug;58(2):341-51
references: 10908302
references: Int J Biochem Cell Biol. 2006;38(8):1254-76
references: 16520081
references: J Pharmacol Exp Ther. 2007 Dec;323(3):907-15
references: 17873105
references: J Pharmacol Exp Ther. 2010 Sep 1;334(3):761-74
references: 20551292
references: Psychopharmacology (Berl). 1998 Aug;138(3-4):217-30
references: 9725745
references: Nature. 1998 Jan 8;391(6663):173-7
references: 9428762
references: J Physiol. 1998 Mar 15;507 ( Pt 3):639-52
references: 9508826
references: Nature. 1987 Jun 11-17;327(6122):515-8
references: 2438558
references: J Neurosci. 2011 Mar 30;31(13):5045-54
references: 21451042
references: J Neurophysiol. 2008 Feb;99(2):999-1007
references: 18094103
references: J Pharmacol Exp Ther. 2007 Oct;323(1):294-307
references: 17625074
references: Planta Med. 2004 Oct;70(10):883-6
references: 15490312
references: Ion Channels. 1996;4:377-450
references: 8744214
references: Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217
references: 10209232
references: J Mol Biol. 1965 May;12:88-118
references: 14343300
references: ChemMedChem. 2009 Nov;4(11):1874-82
references: 19739198
references: Prog Brain Res. 1996;109:125-37
references: 9009699
references: J Neurosci. 2001 Mar 15;21(6):1848-56
references: 11245669
references: Mol Pharmacol. 2006 Sep;70(3):801-5
references: 16766716
references: J Mol Neurosci. 2011 Sep;45(1):42-7
references: 21424792
references: J Pharmacol Exp Ther. 1996 Jan;276(1):289-97
references: 8558445
references: J Pharmacol Exp Ther. 2006 Sep;318(3):1108-17
references: 16738207
references: J Mol Neurosci. 2005;27(1):13-21
references: 16055943
references: Z Naturforsch C J Biosci. 2002 Nov-Dec;57(11-12):1056-61
references: 12562094
references: J Neurosci. 2009 Jan 28;29(4):918-29
references: 19176801